Patents by Inventor Rizwan Sharnez

Rizwan Sharnez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11958882
    Abstract: Disclosed herein are methods of preparing a composition comprising crystalline biomolecules, for example, crystalline antibodies. In exemplary embodiments, the method comprises forming a fluidized bed of crystalline biomolecules using, for example, a counter-flow centrifuge to exchange buffer and/or to concentrate the crystalline biomolecules in a solution. Also provided are methods of detecting crystalline biomolecules and/or amorphous biomolecules in a sample.
    Type: Grant
    Filed: March 14, 2018
    Date of Patent: April 16, 2024
    Assignee: AMGEN INC.
    Inventors: Rizwan Sharnez, William Trieu, Marc A. Caporini, Ron C. Kelly, Neill Burt, Laura Nicholson, Twinkle R. Christian
  • Publication number: 20200157141
    Abstract: Disclosed herein are methods of preparing a composition comprising crystalline biomolecules, for example, crystalline antibodies. In exemplary embodiments, the method comprises forming a fluidized bed of crystalline biomolecules using, for example, a counter-flow centrifuge to exchange buffer and/or to concentrate the crystalline biomolecules in a solution. Also provided are methods of detecting crystalline biomolecules and/or amorphous biomolecules in a sample.
    Type: Application
    Filed: March 14, 2018
    Publication date: May 21, 2020
    Inventors: Rizwan Sharnez, William Trieu, Marc A. Caporini, Ron C. Kelly, Neill Burt, Laura Nicholson, Twinkle R. Christian
  • Patent number: 6210574
    Abstract: A system for separating nucleated cells from a blood sample includes a charge-flow separator (CFS), which separates blood into fractions according to the surface charge density characteristics coupled with an affinity-filtration separator which either outputs a separated blood fraction to the CFS or receives a separated blood fraction from the CFS. The system permits separation of nucleated fetal red blood cells, erythroid progenitor cells and other nucleated cells found in blood samples.
    Type: Grant
    Filed: May 24, 1999
    Date of Patent: April 3, 2001
    Assignee: BioSeparations, Inc.
    Inventors: David W. Sammons, Garland E. Twitty, Joseph G. Utermohlen, Rizwan Sharnez
  • Patent number: 5906724
    Abstract: A charge-flow separation apparatus (CFS) for enriching rare cell populations, particularly fetal cells, from a whole blood sample by separating the rare cell fractions from whole fractions according to the relative-charge density and/or the relative binding affinity for a leukocyte depletion solid phase matrix is described. The apparatus having an internal cooling system allows for dissipating heat generated by the electric field of the apparatus. The internal cooling system, consisting of a plurality of cooling tubes to circulate coolant material, prevents cellular degradation typically associated with the high heat generated by the electric field and permits the use of a higher voltage gradient to shorten separation times.
    Type: Grant
    Filed: July 23, 1997
    Date of Patent: May 25, 1999
    Assignee: BioSeparations, Inc.
    Inventors: David W. Sammons, Garland E. Twitty, Joseph G. Utermohlen, Rizwan Sharnez
  • Patent number: 5662813
    Abstract: A charge-flow separation apparatus (CFS) and method for enriching rare cell populations, particularly fetal cells, from a whole blood sample by separating the rare cell fractions from whole according to the relative charge density and/or the relative binding affinity for a leukocyte depletion solid phase matrix. The enrichment method may be operated stand alone, or as a pre- or post-processing step in conjunction with a charge-flow separation method.
    Type: Grant
    Filed: October 21, 1994
    Date of Patent: September 2, 1997
    Assignee: BioSeparations, Inc.
    Inventors: David W. Sammons, Garland E. Twitty, Joseph G. Utermohlen, Rizwan Sharnez
  • Patent number: 5439571
    Abstract: An apparatus and method of continuous flow zone electrophoresis for separation of particulates or biological samples, including cells and sub-cellular components, in a separation chamber configured to enhance separation of the sample components. The peak-to-peak distance between sample components in a non-equilibrium continuous flow zone electrophoretic fractionator is amplified by selective manipulation of particle residence time within the separation chamber.
    Type: Grant
    Filed: November 19, 1991
    Date of Patent: August 8, 1995
    Assignee: Bioseparations, Inc.
    Inventors: David W. Sammons, Rizwan Sharnez
  • Patent number: 5173164
    Abstract: A preparative scale multi-mode electrical separator, which is matrix-free and may be operated in both a batch mode and a continuous, flow-through mode is provided. It may be scaled according to the solution quantities which are to be processed. An internal cooling system whereby the process fluid is always in close proximity to a chilled surface assures an efficient heat dissipation during the separation and concentration processes and also allows the use of higher voltage gradients and shorter separation times than prior designs of electrophoretic separators. Electroosmotic mixing is reduced by providing internal, compartmentation of sample fractions, focusing is improved and focusing times are decreased. Different electrophoretic methods, including zone electrophoresis, isoelectric focusing, counterflow gradient focusing or electrodialysis, may be used with the separator. It may be applied to the purification of proteins, ions, and microorganisms, and for water purification.
    Type: Grant
    Filed: September 11, 1990
    Date of Patent: December 22, 1992
    Assignee: Bioseparations, Inc.
    Inventors: Ned B. Egen, Garland E. Twitty, David W. Sammons, Rizwan Sharnez